These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35095077)

  • 21. Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes.
    Kim JH; Singh R; Pagani FD; Desai SS; Haglund NA; Dunlay SM; Maltais S; Aaronson KD; Stulak JM; Davis ME; Salerno CT; Cowger JA; Shah P;
    J Card Fail; 2016 Dec; 22(12):981-987. PubMed ID: 27765670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
    Demirozu ZT; Arat N; Kucukaksu DS
    Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slope of the anterior mitral valve leaflet: a new measurement of left ventricular unloading for left ventricular assist devices and systolic dysfunction.
    Martinez SC; Bradley EA; Novak EL; Rasalingam R; Cedars AM; Ewald GA; Silvestry SC; Joseph SM
    Tex Heart Inst J; 2014 Jun; 41(3):262-72. PubMed ID: 24955040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
    Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Right ventricular free wall longitudinal strain and stroke work index for predicting right heart failure after left ventricular assist device therapy.
    Gumus F; Durdu MS; Cakici M; Kurklu TST; Inan MB; Dincer I; Sirlak M; Akar AR
    Interact Cardiovasc Thorac Surg; 2019 May; 28(5):674-682. PubMed ID: 30561630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.
    Verma AK; Sun JL; Hernandez A; Teerlink JR; Schulte PJ; Ezekowitz J; Voors A; Starling R; Armstrong P; O'Conner CM; Mentz RJ
    Clin Cardiol; 2018 Jul; 41(7):945-952. PubMed ID: 29781109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients.
    Brenyo A; Rao M; Koneru S; Hallinan W; Shah S; Massey HT; Chen L; Polonsky B; McNitt S; Huang DT; Goldenberg I; Aktas M
    J Cardiovasc Electrophysiol; 2012 May; 23(5):515-20. PubMed ID: 22081967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device.
    Yoruk A; Sherazi S; Massey HT; Kutyifa V; McNitt S; Hallinan W; Huang DT; Chen L; Aktas MK
    Heart Rhythm; 2016 May; 13(5):1052-1056. PubMed ID: 26829113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart failure etiology and risk of right heart failure in adult left ventricular assist device support: the European Registry for Patients with Mechanical Circulatory Support (EUROMACS).
    Løgstrup BB; Nemec P; Schoenrath F; Gummert J; Pya Y; Potapov E; Netuka I; Ramjankhan F; Parner ET; De By T; Eiskjaer H
    Scand Cardiovasc J; 2020 Oct; 54(5):306-314. PubMed ID: 32552049
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
    Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
    Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to Estimate the Optimal Heart Rate in Patients with Heart Failure with Preserved Ejection Fraction.
    Izumida T; Imamura T; Fukui T; Koi T; Ueno Y; Hori M; Nakagaito M; Tanaka S; Kataoka N; Ushijima R; Nakamura M; Sobajima M; Fukuda N; Ueno H; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):816-820. PubMed ID: 34276013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation.
    Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Bhat G; Cowger J; Abdullah M; Dhawan R; Trivedi JR; Slaughter MS; Gopinathannair R
    Sci Rep; 2020 Feb; 10(1):2573. PubMed ID: 32054868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
    Mulder BA; Damman K; Van Veldhuisen DJ; Van Gelder IC; Rienstra M
    Clin Cardiol; 2017 Sep; 40(9):740-745. PubMed ID: 28513877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction.
    Sartipy U; Savarese G; Dahlström U; Fu M; Lund LH
    Eur J Heart Fail; 2019 Apr; 21(4):471-479. PubMed ID: 30698317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
    Starling RC; Estep JD; Horstmanshof DA; Milano CA; Stehlik J; Shah KB; Bruckner BA; Lee S; Long JW; Selzman CH; Kasirajan V; Haas DC; Boyle AJ; Chuang J; Farrar DJ; Rogers JG;
    JACC Heart Fail; 2017 Jul; 5(7):518-527. PubMed ID: 28396040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
    Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
    Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D echocardiography derived right ventricular function is associated with right ventricular failure and mid-term survival after left ventricular assist device implantation.
    Magunia H; Dietrich C; Langer HF; Schibilsky D; Schlensak C; Rosenberger P; Nowak-Machen M
    Int J Cardiol; 2018 Dec; 272():348-355. PubMed ID: 29903518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.